Close

Canaccord Genuity on Life Sciences/Biomedical Devices and Services: 2012 Best Ideas: Investing for Growth or Value Dec 15, 2011 09:21AM
Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Resetting the Bar Dec 12, 2011 08:28AM
Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part I Dec 7, 2011 09:32AM
DexCom To Present at Upcoming Investor Conferences Nov 7, 2011 04:05PM
Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Q3 Miss; Q4 Revenue Guidance Lowered, Resetting the Bar Appropriately Nov 3, 2011 09:59AM


Jul 5, 2011 08:14AM Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Takeaways from ADA; FDA Mandated Sensor Shut-off a Possibility in Future
Jun 3, 2011 08:47AM Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Animas Receives CE Mark Approval for VIBE (Combo CGM/pump); Milestone Due
May 4, 2011 11:17AM Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Light Q1/11 New Patients Adds on Seasonal Weakness; Demand Still Strong
May 3, 2011 11:25AM Canaccord Genuity on Life Sciences -- Biomedical Devices and Services: Q1/11 Diabetes Quarterly Preview: DXCM and PODD
Mar 4, 2011 11:14AM Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Q4 In Line With positive Preannouncement; New Patients & Higher Utilization Drive Results
Nov 5, 2010 11:49AM Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Q3/10 Strong, Fundamentals Outweigh FDA Delays; Buy on Pullback
Aug 18, 2010 11:06AM Canaccord Genuity on Life Sciences -- Biomedical Devices and Services: Takeaways from Global Growth Conference Part II
Aug 4, 2010 12:18PM Canaccord Genuity Reiterates a 'Buy' Rating on DexCom (DXCM); Strong Q2/10 Demonstrates Momentum